RYTM CIK: 1649904

Rhythm Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−146
FY22:
−173
FY23:
−136
FY24:
−114
FY25:
−116
Change from FY21 to FY25
millions USD
FY21:
−62.2
FY22:
28.0
FY23:
−5.67
FY24:
−48.2
FY25:
−137
Change from FY21 to FY25
millions USD
FY21:
166
FY22:
214
FY23:
74.4
FY24:
191
FY25:
218
millions USD
FY21:
−41.7
FY22:
68.4
FY23:
−67.6
FY24:
29.2
FY25:
−34.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−146
FY22:
−174
FY23:
−136
FY24:
−114
FY25:
−117

All amounts in millions USD Data source:SEC EDGAR